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Abstract 
 
This discussion paper aims to offer an overview and 
working definition of translational research, appropriate to 
health. Methods: Using scholarly and applied literature, the 
paper first identifies key challenges in achieving evidence-
based policy and practice. It highlights international policy 
interest in new approaches to evidence translation and the 
barriers to achieving sound evidence translation. The paper 
offers an explicit definition of translational research and 
explains why it is important to have such a definition. It 
then elaborates on this definition by identifying and 
exploring seven distinctive research practices that could be 
associated with translational research. Findings and 
conclusions: Translational research is research with a sense 
of place. Its defining feature is excellence in evidence for a 
specific context or sphere of action, whether that is health 
policy for the World Health Organisation or service design 
for a local non-government organisation. If research is to be 
translated at all, it needs to be meaningful to many specific 
contexts, including small and regional contexts. The best 
promise that translational research offers is of exciting new 
techniques to achieve rigour and systemacy for such 
localised ‗real world‘ policy, service and practice contexts.  
 
Keywords: Translational research, policy development, 
evidence-based practice. 
 
 
Introduction 
 
‗Evidence-based policy‘ and ‗evidence-based 
practice‘ are defining terms of our age, not just in 
health, but many sectors. Research today must meet 
the needs for integrated ‗whole-of-system‘ policy 
development as well as ‗whole-of-patient‘ practitioner 
decision-making.  
However, ongoing efforts to develop better 
healthcare face great obstacles to do with achieving 
evidence-based decision and action. Many best 
practice clinical guidelines are still not used in service 
delivery, and many practitioners lack access to 
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practical and conceptual resources for integrating 
clinical research findings into their daily practice (1). 
Available information on the performance of 
healthcare services in Australia and overseas suggests 
undesirable variations (2,3). The critical studies 
needed to address these variations remain undone in 
even developed nations such as the USA where they 
have been observed for at least a decade (3). The 
health policy literature offers evidence that too much 
policy at the micro, meso and macro levels has been 
shaped without access to sound evidence. Policy 
decision-making is too often shaped by political or 
economic imperatives that have little to do with 
healthy outcomes. It is also often hard for policy-
makers to use or apply the evidence because the 
context—particularly in primary and community 
healthcare—is so dynamic and highly variable itself.  
Yet developing countries invest heavily in health 
research. Much of the world‘s health evidence base is 
contributed by The United States of America (USA). 
About half of web citations of health-related scientific 
papers are authored in the USA, however, the USA 
has only 4% of the total global population and a tiny 
portion of the global disease burden (4). This has 
important implications for the relevance and 
usefulness of evidence. Methodologies, evidence 
bases, and interventions developed in the USA 
context do not always translate well to other service 
contexts. For example, rural health practitioners and 
policy-makers often need to make decisions for small 
populations in diverse local contexts using a relatively 
homogenous urbanised evidence base (5). Health 
programs such as chronic disease self-management 
education programs can require considerable 
translation to be useful for remote Australia. 
However, the Lorig USA-based studies do not 
prefigure such problems of evidence transfer (6,7). 
Health service research comprises a tiny fraction 
of the growing health research quantum. The USA 
doubled its biomedical research funding over the 
1990s to spend up to 5.6% of total health expenditures 
on biomedical research by the beginning of the new 
century (8,9). However, in 2002 just 1.5% of 
biomedical research funding was spent on health 
services research (8). From 2000 to 2009 the 
Australian National Health and Medical Research 
Council‘s (NHMRC) research expenditure increased 
by a factor of four. However, funding increased for 
health services research only threefold (from 1.4% of 
total NHMRC funding in 2000 to 4.2% by 2009) (10). 
 
 
Conceptualizing the key translational 
challenges 
 
The 2001 America‘s Institute of Medicine report 
Crossing the Quality Chasm, observed that despite 
enormous increases in discovery-oriented basic 
science and technology, community benefits lagged 
behind with a healthcare system that too frequently 
fell short in ‗its ability to translate knowledge into 
practice‘(11). This concern—that much research was 
not being used—became a point of departure for the 
US National Institutes of Health‘s emphasis on 
translational research in its 21
st
 Century research 
roadmap. Three key kinds of translational hurdles 
have been identified: between basic science 
researchers and clinical triallists, between clinical 
research and clinical practitioners; between clinical 
practitioners and patients who are the ultimate 
knowledge translators (1). Such translational hurdles 
are the subject of an emerging specialised field of 
enquiry into clinical knowledge translation, reflected 
in a growing body of literature, journals such as 
Implementation Science, as well as the operational 
arrangements of key bodies such as the Canadian 
Institutes of Health Research which has a division of 
‗knowledge translation‘ (1). 
In the health policy literature, the translational 
challenges have also been conceptualised not only in 
terms of 1)how well research is translated across the 
disciplines of health, but also in terms of 2)how well 
research is translated into ‗real world‘ policy, as well 
as 3)how well policy is translated between policy-
makers and their communities of interest. 
 
 
Increasing recognition of the need for 
translational research 
 
Here in Australia, the final report of the National 
Health and Hospitals Reform Commission suggested 
that evidence-based practice and policy will be critical 
to delivering the reforms needed if Australia‘s 
healthcare system is to improve (12). Other recent 
Australian policy reports such as the discussion paper 
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The Healthiest Country by 2020 discussion paper (13) 
suggested the importance of meeting the three 
translational challenges just referred to:  
 
 researcher to researcher 
 researcher to practitioner and policy-maker  
 practitioner or policy-maker to clients or 
communities of interest.  
 
In Taking Preventative Action (14) the Australian 
government articulates its plan to gather, analyse and 
disseminate the available evidence and evidence-
based programs to prevent disease. Yet there is little 
indication that there will be funding streams to deliver 
on these policy reports, including for translational 
research programs. 
Internationally, there is also evidence of an 
increasing recognition that reform and development 
of health systems to meet present challenges will 
require fostering new styles of translational research 
that go beyond traditional applied or action research 
methods.  
Canada‘s Health Research Roadmap: Creating 
innovative research for better health and healthcare 
(15) offers a strong translational research vision for 
the Canadian Institutes of Health Research that 
includes valuing solutions-focussed research and 
increasing the uptake of research. Research into 
health systems challenges that deliver innovation in 
the practitioner-patient interface is recognised as 
critical, especially in the wake of the global economic 
recession (15). Work by the Canadian Institutes of 
Health Research and The University of Toronto has 
also led to an important book Knowledge Translation 
in Health Care which offers a collection of papers on 
wide-ranging issues of knowledge translation. It 
suggests the sophistication of both theoretical 
understandings and practices in that country as they 
relate to translational research and implementation 
science: the definitions of knowledge translation, 
strategies for fostering knowledge translation that 
have relevance to practitioners and policy-makers as 
well as translational researchers (16). 
The UK‘s Medical Research Council appear to be 
taking a similar approach in their Medical Research 
Council‘s 2009-2014 Strategic Plan. This document 
offers four key strategic aims that include ‗Picking 
research that delivers‘ including in areas such as 
‗addressing the complex interplay between genetics, 
development, and life events or lifestyles‘. In 
particular, aim two ‗research to people‘ states that: 
 
―The MRC will work with researchers in both public and 
private sectors, regulators, and the breadth of stakeholder 
communities to ensure that research of the highest quality is 
translated into tangible benefits for society as a whole. 
Objectives: Translation of research: To bring the health 
impacts of fundamental research to people more quickly. 
Regulation, ethics, governance and working with decision-
makers: To uphold and guide ethical research practice and 
the highest standards of research governance; to enhance 
the regulatory process by providing innovative approaches. 
Communication: To enhance communication with 
scientists, the public, policy-makers and partners‖ (17) 
 
New Zealand‘s Health Research Council‘s 
Strategic Plan 2008-13, also contains a strong 
translational focus. The second of its four goals is to 
‗Maximise the benefits of health research‘. This 
involves the following ‗key activities‘: 
 
 ―Undertake research outcome evaluations 
 develop user-friendly research findings 
database 
 Continue to develop and improve web 
offerings as a key knowledge resource 
 Introduce processes that link previous 
contract performance with future funding 
 decisions 
 Work with health sector to evolve 
mechanisms for communication and uptake 
of 
 translational research findings 
 Support research champions in policy and 
service delivery environments 
 Grow partnering arrangements‖(18)  
 
The World Health Organisation‘s policy on 
research for health, contained in its 2007 report 
Strengthening Health Systems to Improve Health 
Outcomes: WHO's Framework for Action (19) 
outlines the critical need for research that addresses 
the needs of health systems and services. It offers a 
framework with six key features: ―service delivery; 
health workforce; information; medical products, 
vaccines and technologies; financing; and leadership 
and governance‖ (19). 
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The „research quality‟ conundrum: Assessing 
the real value of research 
 
However, what mechanisms might achieve this 
translation remains uncertain in many countries. In 
the Australian health sector such translational 
research challenges appear relatively less well 
theorised with reference to what is known about 
evidence transfer and less well operationalised. This 
is so even, or perhaps especially, in the light of the 
NHMRC‘s recent Draft National Strategy for Medical 
Research and Public Health Research, which places a 
strong emphasis on translating knowledge through 
research partnerships, centres for research excellence, 
collaborative research initiatives and grants for 
commercial development (20).  
Further, what is known about research usefulness 
too often does not seem to inform frameworks that 
measure the quality of research and drive the 
production of ever more research. These quality 
frameworks are often driven by research 
establishments that favour impacts in research 
communities rather than (ostensibly harder to 
measure) impacts in policy and practice. Current 
quality framework trends in Australia are 
demonstrated by the Australian Research Council‘s 
2010 final draft rankings of academic journals: in 
health disciplines these rankings omit or more lowly 
rank Australian journals, interdisciplinary journals, 
journals produced for health practitioners and policy-
makers, and journals with a health service orientation. 
Unless greatly revised, this quality framework for 
Australian research will exclude many forms of 
research with a high social impact or a practitioner 
and policy focus. The ERA rankings can to a limited 
extent address research output, but cannot address 
research uptake and accessibility and related issues. 
For example, a focus on published work creates a risk 
of bias: negative results either remaining unpublished 
or published in perceived lower quality journals that 
will in turn affect the potential for the ‗whole picture‘ 
to be seen and will lead to uptake of incomplete 
evidence. 
The development of Australia‘s journal rankings 
for the ERA framework has created a focus on A and 
Aplus ranked journals in the academic research 
industry in that country that does not appear to reflect 
the important thinking, developments, methods and 
evidence offered by the literature on what is known 
about evaluating the return for communities of 
different kinds of investments. For example, a ‗social 
return on investment‘ analysis of community 
development work by the Community Development 
Foundation and the new Economics Framework in the 
UK (21) suggests how the true return on investments 
in community development—typically a feature of 
more applied, community-based, and practitioner-
oriented research—can be measured. For example, the 
report suggests that the benefits of research that is 
oriented to community development (‗CD‘) is much 
higher than previously acknowledged: ‗community 
development creates £2.16 of social and economic 
value for every £1 invested‘ and ‗for each £1 a local 
authority invests in a CD worker, £6 of value is 
contributed by community members in volunteering 
time‘ (21).  
In Australia, Community Indicators Victoria 
(CIV) a collaborative project hosted by the 
McCaughey Centre at the School of Population 
Health, University of Melbourne, provides ‗a 
community well-being indicator framework with local 
level data‘. ‗Well-being data‘ can be accessed via 
‗Well-being reports‘ based on ‗Well-being indicators‘ 
that are used in community engagement exercises to 
develop understandings of goals and priorities leading 
to better policy development, planning and action 
planning, supported by better reporting of progress 
towards these goals. The CIV also offers (trademark) 
‗Results Based Accountability‘, a systematic 
approach to thinking about and taking action in 
relation to improving the quality of life in different 
kinds of communities, small and large. ‗Results Based 
Accountability‘ is also relevant to improvement of the 
performance of programs, as well as agencies and 
service systems (http://www.communityindicators. 
net.au/). 
Such approaches to measuring community 
benefits have application to the task of understanding, 
measuring, and improving the benefits that research 
brings to communities. They suggest that research 
that is more directly focussed on the contexts of real 
world communities has benefits for society as a whole 
that should be accounted for in valid notions of 
research impact and value. The value for the 
community of narrow notions of research quality need 
to be challenged through cost-benefits analyses that 
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measure the real return for the community on research 
investment. Unless that is done, narrow notions of 
research quality will continue to be supported by 
faulty, vague and unexamined assumptions of value 
more suggestive of the academic status quo than the 
national interest or national health agenda. 
 
 
Questioning within universities about research 
practice 
 
The idea that meeting the challenges of evidence-
based policy and practice will involve questioning not 
only narrow notions of research quality, but also the 
ways in which research is practiced, published and 
communicated has been gaining ground in health and 
many other disciplines.(5) In health, the debates 
around extending classical experimental methods to 
make them more useful for ‗real world‘ decision-
making contexts have resulted in new methodological 
models badged as ‗pragmatic clinical trial‘ designs 
integrating for example, cost-benefit analyses, as 
suggested by the work of Tunis and others (22,23). 
The struggle in social epidemiology to capture 
neighbourhood complexity is in part a revisionist 
struggle to engage with causal complexity in a way 
that is meaningful for ‗real world‘ decision-making 
(5,24-26). Nursing research has questioned and 
developed more socially authentic methods for 
engaging with the interface between practitioners and 
patients including through innovative language-
centered applications of methods such as hermeneutic 
analysis and critical discourse theory (27,28). Yet 
nursing research—even, and perhaps especially, when 
designed to be fit for purpose—often struggles with 
perceptions that it is somehow of less importance than 
that emanating from medically qualified and/or 
biomedical researchers. 
Yet the most vigorous questioning of the social 
relevance of both traditional quantitative and 
qualitative research methods has come from outside 
the health sciences. This has been accompanied by a 
reworking of those methods (5). The rise of celebrated 
case-based analysts in the social sciences such as 
Ragin (29), Rihoux (30), George and Bennett (31) 
have been part of a sustained re-thinking of the place 
of traditional research methods. Ragin acknowledged 
the well-known problems of generalisability that 
much qualitative and case study research has for high-
stakes real world decision-making. His book Fuzzy-
Set Social Science is widely acknowledged as one of 
the most sustained and persuasive critiques of the 
traditional statistical methods in the last few decades. 
Building on his earlier work What is a Case?(32) 
Ragin engages with the technical assumptions of 
classical statistical methods to suggest that these 
‗variable-driven‘ methods have often failed the test of 
social relevance because they fail to engage with the 
causal complexity of policy and practice contexts 
(29). The challenge of making research more useful 
is, according to Ragin, not about translating or 
reproducing research evidence in different forums and 
genres, as if policy-makers and practitioners need a 
watered-down version of this research to help them 
understand it better. He offers an alternative in his 
model of quali-quantitative case-based analysis which 
has been published in over 250 applications across 
different disciplines (30).  
The emerging field of health policy research led 
by Davies and Nutley (33) in the United Kingdom 
(UK), and Lavis (34,35) in Canada also provides 
strong evidence, including from studies of policy-
makers, that traditional research approaches often 
have poor transferability to policy-making contexts 
because they have homogenising and simplifying 
tendencies. Paradoxically, the technical form of 
statistical evidence can often take on a seeming 
complexity or inaccessibility by lay readers even, and 
perhaps especially, when it is homogenising and 
simplifying complex causality with what Ragin calls 
‗correlational thinking‘ (36). 
The health policy research and the wider policy 
research suggest that Ragin may be right. While there 
are many barriers to the transfer of research, including 
its timeliness, there is a disconnect between research 
methods and what is needed to achieve change in 
local contexts (37-39). This disconnect is also 
apparent in the implementation science literature on 
evidence transfer into clinical practice (1). 
 
 
Defining translational research 
 
The term ‗translational research‘ has really only 
become part of the research lexicon in the 21
st
 
Century. Almost all of the literature yielded by 
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searches on variations of this term was published 
from 2000 onwards.  
Translational research has been described as 
being about the goal of realising the full clinical 
promise of new basic science or ‗laboratory‘ 
knowledge in areas such as molecular biology, the 
genome, neuroscience, immunology and so on, in new 
therapeutic ways. As such, it focuses on developing 
bio-medical knowledge for the practical needs of 
clinical diagnosis, treatment and prevention (4,40). 
The ‗two-way street‘ of translational research 
emphasises not only the transfer of research into 
clinical practice but also the translation of clinical 
insights into research practice through, for example, 
the development of hypotheses (40). 
However, translational research is a term that has 
included a broad church of researchers beyond this 
‗two way street‘ for clinical research and practice. 
The term has been used to include many kinds of 
health services and policy-oriented research as well as 
a wide range of multidisciplinary research for holistic 
health interventions, from the treatment of asthma in 
children to adolescent substance abuse to chronic 
diseases in older people. 
How then should translational research be 
defined? The best definition of translational research 
is one that works to promote excellence in research 
for health policy and practice. Such a definition could 
be a tool for realising this excellence through new 
theoretical understandings, strategies and operational 
arrangements for helping research make a difference. 
Within university health science departments this 
definition could become a rallying point for building 
research capacity, identity and morale, reducing 
wastage of those many researchers who lie at the 
margins of narrow and singular ‗gold standards‘ for 
research quality. This definition could help focus 
talent on addressing critical gaps, especially in a 
climate where ‗metrics‘ of research quality and value 
define ‗who‘ is doing research rather than ‗what‘ 
knowledge is being used in what ways. Beyond 
universities, such a definition could work to support 
the legitimacy of claims policy-makers, practitioners, 
and patients make that there be a good return on a 
country‘s health research investments. Such a 
definition could also work to strengthen the social 
contract between universities and their communities, 
building shared understandings that while quality and 
usefulness in health research are not the same, they 
should be related.  
Achieving an agreed-on ideal of translational 
research such as this is clearly a goal that must be 
worked for over time. However, a preliminary broad 
working definition of ‗translational research‘ can be 
developed from the translational research literature 
and is given in Box 1. 
 
Box 1. A working definition of translational research 
 
 
Translational research is systematic, 
transdisciplinary research based on a well-
developed model of producing or transforming 
research evidence for the specific local contexts of 
health and allied health practice and policy. It 
offers new evidence-based tools and resources for 
practical application in health prevention, pre-
emption, intervention, and follow-up. It may also 
offer new health policy frameworks, health service 
designs and models for services development in 
those local contexts. Such tools, resources and 
information may be transformed or developed 
from a pre-existing or new body of research 
evidence. Translational research may also include 
developing new research methods for delivering 
more useable evidence for practice and policy. 
 
 
‗Transdisciplinary research‘ in this context is 
research that, by combining elements of different 
approaches from different disciplines, offers 
genuinely new approaches that are more than simply 
‗multidisciplinary‘. That is, transdisciplinary research 
involves synergising new approaches using elements 
of methods from different disciplines. The foregoing 
definition of translational research differs from the 
operational definition of translational science used by 
America‘s National Institutes of Health (NIH) 
because it goes beyond the idea of a creating a two-
way street from laboratory bench to clinical medical 
bedside and vice versa. It overlaps with the NIH 
definition because it focuses on ‗research aimed at 
enhancing the adoption of best practices in the 
community‘. Yet it goes beyond this to include a wide 
group of practitioners in health and allied health areas, 
as well as policy-makers wanting to adopt ‗whole-of-
systems‘ approaches to complex health challenges. It 
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also shares with the operational NIH definition an 
emphasis on the idea of ‗science‘ as broadly covering 
‗the discovery of new knowledge about health and 
disease prevention, pre-emption, and treatment; as 
well as methodological research to develop or 
improve research tools‘ (41). 
From the perspective of translational research, 
discovery-oriented research is one step in the 
production of evidence for policy and practice. In 
translational research, the work of designing policy 
frameworks or tools for practitioners is seen as also 
involving an original contribution, albeit in a 
different kind of science and style of excellence.  
 
 
A distinctive set of research practices 
 
All research is to some extent translational—although 
we have been very comfortable with the distinction 
implied by the terms ‗applied research‘ and 
‗experimental research‘ for a long time. Much health 
research can be located along a continuum in terms of 
the extent to which it suggests elements of the 
working definition. However, for the purposes of 
analysis, seven distinctive research practices of 
translational research can be identified using the 
broader evidence transfer literature (42). 
First, translational research involves an 
engagement with policy-makers and practitioners in 
deciphering the local particulars of the research 
question (42). A focus on local context has been 
found to be positively associated with evidence 
transfer (43). This involves bringing together the local 
contextual evidence with the national and 
international evidence. It can involve deciphering the 
pragmatic dimensions and constraints, possible trade-
offs, uncertainties, and so on, of local policy or 
practice contexts. It can also involve a focus on 
implementation issues such as sustainability. One of 
the useful conceptual models for doing this is 
presented in a paper by Walker and colleagues, 
‗Defining uncertainty: A conceptual basis for 
uncertainty management in model-based decision 
support‘ (44). The 2004 National Health Service 
report Choosing Health: Making Choices Easier 
offers examples of this focus on local context. It 
grapples with the policy problems of helping people 
manage their own health in ways that lead to healthy 
choices. It describes very specific constraints in the 
UK to do with social attitudes, constraints to do with 
free markets and so on, as well as the contextualised 
history of policy efforts in areas such as under-age 
smoking (45). Second, translational research involves 
new reviewing styles for the inclusion of not just 
‗gold standard‘ research understood as randomised 
clinical trials but also a wide range of possible 
evidence that falls outside this category (42). A whole 
body of literature has developed offering techniques 
for translational reviewing, revitalising traditional 
reviewing methods. For example, the influential work 
of Pawson and Tilley in the social sciences and their 
‗realistic evaluation‘ methodology challenges many of 
the tenets and highlights the limitations of the 
classical experimental model which they say has 
failed policy-makers across many sectors (46-49). 
Their focus is upon using diverse sources to 
understand the underlying mechanisms that make 
interventions work in specific contexts (48). 
Government agencies such as the Cabinet Office of 
the UK Government have become active in 
developing new guidelines offering alternative models 
of assessing the quality of, and integrating, different 
kinds of evidence as part of such translational 
research practices (50). Over the last decade a host of 
agencies have been established to meet such 
translational review challenges: The Evidence for 
Policy and Practice Information and Co-ordinating 
Centre (EPPI-Centre) in London (http://eppi.ioe.ac. 
uk); The ESRC UK Centre for Evidence-based Policy 
and Practice (http://www.esrcsocietytoday.ac.uk/ 
ESRCInfoCentre/index_academic.aspx ); The 
Campbell Collaboration (http://www.campbell 
collaboration.org/); and in the USA agencies such as 
the Resource Center for Health Policy at the 
University of Washington (http://depts.washington. 
edu/rchpol).  
Third, translational research is characterised by 
innovative transdisciplinary research methods with 
intelligent designs for policy and practice. These 
methods reflect a notion of quality that values not 
only internal research validity but also external or 
social validity. An engagement with the complex 
causality at work in specific policy and practice 
contexts is their defining note (42). Examples include: 
futures scenario modelling or forecasting methods 
(51,52) for health policy; street level operations 
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research for hospital performance (53); small-N case 
based methods (29) for comparing health systems.  
Fourth, translational research involves a focus  
on consensus-building (consensus-finding and 
consensus-making) to achieve change in communities 
of interest, consistent with best practice in the 
growing science of community engagement (42). In 
health the science of participatory research practices 
is represented in, for example, the book edited  
by Minkler and Wallerstein Community-based 
Participatory Research for Health (54). The field of 
community-based research for health suggests that 
new science in such techniques as the PANDA 
(Participatory Appraisal of Needs and Development 
of Action) designed by White and Taket (55-57) or 
the Q-methodology for identifying stakeholders and 
their issues developed by Ellis and colleagues (58). 
However, despite exhortations for, and studies 
showing the importance of, participative approaches 
for evidence-based policy and practice (59), it is 
known that only a minority of health researchers 
involve health stakeholders (60).  
However, the need for localised, community-
based research of different kinds will persist. In 
Australia, the creation of local primary care 
organisations ('medicare locals‘) and local hospital 
networks has been accompanied by an idea of quality 
that is about being responsive to the local and 
particular. At the Kings Fund in the UK there has 
been a strong emphasis on the use of action learning 
cycles and the creation of communities of practice in 
micro systems at the local level, in ways that include 
patients and carers. For example, in relation to 
avoiding hospital admissions, recent work by the 
Kings Fund suggests that some interventions being 
used in the NHS do not work very well and that 
approaches that create micro communities of learning, 
such as the Wandsworth community virtual wards 
‗replicating the multidisciplinary approach of the 
hospital ward in the community‘ are likely to work 
better (61).  
Fifth, translational research can also include 
delivering evidence in a form that is persuasive to 
policy-makers, practitioners and the wider 
community. The work of Stone (62) and others in the 
field of policy analysis has demonstrated the critical 
role of policy argument in delivering evidence to 
policy-makers and their communities: the art of 
crafting empirical data into persuasive ‗causal stories‘ 
(63) and data-driven arguments about for example, 
interests, rights, equality and efficiency, and trade-
offs between these (62). Such work is informed by 
state-of-the-art knowledge about numeric and 
language-based sign systems. Some of these 
approaches have been modelled by Nelson, Hess and 
Croyle in their 2009 book Making Data Talk: The 
Science and Practice of Translating Public Health 
Research and Surveillance Findings to Policy 
Makers, the Public, and the Press (39). A practical 
example might be the report Hospital Guide 2008: 
The Health of our Hospitals Revealed (64) which has 
used some of these techniques to make hospital 
performance a cause célèbre in the UK (42).  
Sixth, translational research involves the 
development of models for action that can be 
operationalised in policy and practice. A range of 
literature, from policy analysis (65) through to 
decision-path modelling in evidence-based medicine, 
suggests ways of developing models for action by 
policy-makers and practitioners. This involves 
attention to delivering what is traditionally called the 
research ‗recommendations‘ in a form that maximises 
their take-up in specific contexts. 
An example might be the stepwise service 
development framework provided in a recent study 
from New Zealand A Review of the Quality, Safety 
and Management of Maternity Services in the 
Wellington Region (42,66).  
Finally, translational research is often 
characterised by an active engagement with the 
dissemination and implementation of evidence in 
communities of action. Knowledge about how to 
achieve this spans a quarter of a century from the 
founding work of Weiss (67), to the dissemination 
theory of Rogers (68), to recent notable contributions 
from health by Nutley, Walter and Davies in their 
book Using Evidence: How Research can Inform 
Public Services (33). This suggests that for research 
transfer to happen something more than knowledge of 
that research is needed. Translational research is 
informed by the complexities of taking evidence ‗off 
the shelf‘. It is also about creating iterative, strategic 
processes between the researcher and other 
knowledge purveyors and communities of action, over 
time (42,69). 
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This focus on the more sociological elements of 
public health, including the science of ensuring better 
community participation was pioneered largely in the 
UK, and includes the work of Jennie Popay whose 
1994 edited collection Researching the People‟s 
Health marked a new decade of dissatisfaction with 
the adequacy of classical statistical methods for 
complex health reform agendas. 
 
 
Conclusions 
 
In short, the term ‗translational research‘ lies on the 
horizon of our understanding of how to make research 
more useful. It is not simply about ‗what is‘ (an 
existing body of research methods). It is also about 
‗what could be‘ (new and emerging methods across 
the disciplines). It is research with a sense of place: it 
is defined bya commitment to excellence in evidence 
for a specific context or sphere of action, whether that 
is health policy for the World Health Organisation or 
service design for a local non government 
organisation. Perhaps the greatest limitation of 
existing ‗variable-driven‘, big-N ideas of research 
quality is that they do not impose an expectation that 
evidence-making for local and regional settings can 
be done systematically and to a pitch of excellence. 
Yet if research is to be translated at all, it also needs 
to be meaningful to many such small and regional 
contexts. The best promise that translational research 
offers is of exciting new techniques to achieve rigour 
and systemacy for such localised ‗real world‘ policy, 
service and practice contexts. Some of these new 
techniques are showcased in this book. 
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